Expression and significance of IFNAR1 in oral squamous cell carcinoma

doi:10.19438/j.cjoms.2017.03.010

Abstract

Abstract: PURPOSE: To investigate the expression of type I interferon receptor 1(IFNAR1) in oral squamous cell carcinoma (OSCC) and normal mucosa, and to explore its relationship with clinical pathological characteristics and prognosis. METHODS: The expression of IFNAR1 in 108 cases with OSCC and 16 cases with normal oral mucosa was detected by immunohistochemistry. The relationship between the expression of IFNAR1 in OSCC tissues and clinical pathological characteristics were analyzed. The data were analyzed with SPSS17.0 software package. RESULTS: The expression of IFNAR1 in OSCC was significantly higher than that in normal oral mucosa. The expression of IFNAR1 was closely correlated with T stage, cervical lymph node metastasis, TNM stage and pathological differentiation (P<0.05); while gender, age, location, smoking and drinking had no correlation with IFNAR1 (P>0.05). IFNAR1 expression was an important factor to predict prognosis of OSCC patients with HR=1.879(95% CI=0.967-3.651, P=0.063). Patients with higher expression of IFNAR1 had poorer prognosis shown by Log-rank test (P=0.057). CONCLUSIONS: The expression of IFNAR1 in OSCC was significantly higher than that in normal oral mucosa, and it is a potential risk factor for OSCC. It has a tendency to be related to the prognosis of OSCC patients. IFNAR1 expression in tumor tissues can be a surrogate to select patients who can benefit from interferon alpha treatment in OSCC.

Key words: IFNAR1, Immunohistochemistry, Oral squamous cell carcinoma

CLC Number:

R739.8

ZHU Li-lin, YANG Wen-yi, MA Hai-long, HU Jing-zhou.. Expression and significance of IFNAR1 in oral squamous cell carcinoma[J]. China Journal of Oral and Maxillofacial Surgery, 2017, 15(3): 240-244.

References

[1] Rivera C. Essentials of oral cancer [J]. Int J Clin Exp Pathol, 2015, 8(9): 11884-11894.
[2] Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer [J]. Oral Oncol, 2009, 45(4-5): 309-316.
[3] Zhang SK, Zheng R, Chen Q, et al. Oral cancer incidence and mortality in China, 2011 [J]. Chin J Cancer Res, 2015, 27(1):44-51.
[4] Chill JH, Quadt SR, Levy R, et al. The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding [J]. Structure, 2003, 11(7): 791-802.
[5] Takaoka A, Yanai H. Interferon signalling network in innate defence [J]. Cell Microbiol, 2006, 8(6): 907-922.
[6] de Weerd NA, Samarajiwa SA, Hertzog PJ. Type I interferon receptors: biochemistry and biological functions [J]. J Biol Chem, 2007, 282(28): 20053-20057.
[7] Wang BX, Rahbar R, Fish EN. Interferon: current status and future prospects in cancer therapy [J]. J Interferon Cytokine Res, 2011, 31(7): 545-552.
[8] Wagner TC, Velichko S, Chesney SK, et al. Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors [J]. Int J Cancer, 2004, 111(1): 32-42.
[9] Booy S, Hofland LJ, Waaijers AM, et al. Type I interferon receptor expression in human pancreatic and periampullary cancer tissue [J]. Pancreas, 2015, 44(1): 99-105.
[10] Kamai T, Yanai Y, Arai K, et al. Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis [J]. BMC Cancer, 2007, 7: 159.
[11] Chang LC, Fan CW, Tseng WK, et al. IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9 [J]. Medicine(Baltimore), 2014, 93(29): e349.
[12] Parker BS, Rautela J, Hertzog PJ. Antitumour actions of interferons: implications for cancer therapy [J]. Nat Rev Cance, 2016, 16(3): 131-144.
[13] Wu CF, Andzinski L, Kasnitz N, et al. The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung [J]. Int J Cancer, 2015, 137(4): 837-847.
[14] Bhattacharya S, HuangFu WC, Dong G, et al. Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses [J]. Oncogene, 2013, 32(36): 4214-4221.

[1]	REZIWANGULI·Yasen, MAIREPATI·Maiming, LI Chen-xi, GONG Zhong-cheng. Research progress in the role and mechanism of Porphyromonas gingivalis in promoting oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 186-190.
[2]	LAN Rong, RUAN Min, HAN Nan-nan, WANG Feng. Peri-implant squamous cell carcinoma appeared after implant-restoration in the left mandible: a case report [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 203-205.
[3]	LIU Heng, DUAN Xiao-feng. Research progress of ferritinophagy and related genes FTH1 and NCOA4 in oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 87-91.
[4]	JI Ping-ping, LI Li, WU Yi-fan, HOU Li-li. Effect of transcutaneous electrical acupoint stimulation on myelosuppression in patients with oral squamous cell carcinoma after induction chemotherapy [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 455-460.
[5]	XU Gang, SONG Qi-yi, JIANG Wei-dong, LIU Jing-xiu. Expression and clinical significance of aquaporin 3 in oral mucosal epithelial dysplasia and oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 478-482.
[6]	YANG Song, WANG Ning, ZHAO Shu-chao, LI Heng-yong, GE Sheng-you, ZHOU Kai, SONG Kai, SHANG Wei, FENG Yuan-yong. Expression and clinical significance of chemerin in oral squamous cell carcinoma patients combined with type 2 diabetes [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 390-395.
[7]	ZHANG Yi-yi, YANG Yue-yi, JU Wu-tong, ZHONG Lai-ping. Neoadjuvant immunotarget therapy in patients with locally advanced oral squamous cell carcinoma: report of 2 cases and literature review [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 413-416.
[8]	WEI Dong-liang, LI Zhi, JU Hou-yu, WU Yun-teng, GUO Wei, REN Guo-xin. Mechanism of EGFR-targeted drugs for pain relief in oral cancer [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(3): 219-224.
[9]	SUN Da-wei, ZHANG Yun, ZHU Yong. Effect of shRNA interference Rce1gene expression on the radiosensitivity of oral squamous cell carcinoma cells [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(2): 123-128.
[10]	NUERMANGULI·Yasen, DUOLIKUN·Wufuer, BAIERNA·Wushuoer, YAN Guang-peng. The relationship between serum IL-6, IL-17, TNF-α, IFN-γ levels, clinical characteristics of60patients with oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(2): 141-145.
[11]	QU Chu-xiang, SUN Shu-yang, ZHANG Zhi-yuan. Understanding oral cancer invasion from the perspective of genetic heterogeneity [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(2): 193-197.
[12]	QIAN Min, SHEN Yue-hong, WU Li, YANG Hong-yu. Metastatic small cell neuroendocrine carcinoma of tongue base: a case report, review [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(2): 202-205.
[13]	WANG Yu-xin, WANG Zhi-yong, WANG Yong-gong, WANG Hui-ming, WANG Li-zhen, TIAN Hao, YE Jin-hai, FU Kun, RUAN Min, SUN Chang-fu, SUN Guo-wen, LIU Fa-yu, XU Bi-yun, HOU Jun, LIU Bing, LIU Liang, CHEN Yong-feng, CHEN Zhan-wei, XIAO Can, LI Si-yi, LI Zhi-yong, LI Yong, LI Nan, ZHANG Chen-ping, ZHANG Dong-sheng, ZHANG Sheng, ZHANG Kai, YANG Xi, HE Wei, SU Tong, JI Tong, LIN Li-song, LUO Rui-hua, ZHAO Zhi-li, HU Qin-gang, TANG Zhan-gui, XU Wei-jia, HUANG Zhi-quan, HUANG Xiao-feng, LIANG Yu-jie, HAN Zheng-xue, HAN Wei, JIANG Can-hua, YU Jian-jun, CAI Zhi-gang, LIAO Gui-qing, LIAO Sheng-kai, CAI Hui-ming, WEI Jian-hua. Chinese expert consensus statement on the application of of indocyanine green(ICG) fluorescence imaging in the treatment of oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(1): 1-6.
[14]	LI Xing, XU Fei-hu, YANG Yun-bo, HAN Nan-nan, RUAN Min. Clinicopathological characteristics and prognostic analysis of oral squamous cell carcinoma with parotid lymph node metastasis [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(1): 28-31.
[15]	YANG Yun-bo, WANG Yu-pu, LI Hang, HAN Nan-nan, YAN Ming, RUAN Min. Expression and clinical significance of cystatin A in oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2021, 19(6): 494-499.